Abstract
Main Text Konzo, a disease characterized by sudden, irreversible spastic paraparesis, affecting up to 10% of the population in some regions of Sub-Saharan Africa during outbreaks and is strongly associated with dietary exposure to cyanogenic bitter cassava. The molecular mechanisms underlying the development of konzo, remain largely unknown. Here, through an analysis of 16 individuals with konzo and matched healthy controls from the same outbreak zones, we identified 117 differentially methylated loci involved in numerous biological processes that may identify cyanogenic- sensitive regions of the genome, providing the first study of epigenomic alterations associated with sub-lethal cyanide exposure and a clinical phenotype.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We would also like to thank the funding sources for this project, with DTK being supported by NIH grant NIEHS/FIC R01ES019841, EV being supported by the A. James Clark Distinguished Professor of Molecular Genetics Endowment and MSB being supported by the Fogarty International Center of the National Institutes of Health (NIH) under Award Number D43TW009343 and the University of California Global Health Institute (UCGHI); The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or UCGHI.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Informed consents were obtained verbally by investigators who are fluent in Lingala and/or Kikongo the local spoken languages. Ethical approval of research activities including informed consent was obtained from the Oregon Health & Science University (OSHU) IRB FWA00000161 and from the Ministry of Health of the Democratic Republic of the Congo (DRC).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The datasets generated and analysed during the current study are available in the GEO repository (GSE180119), https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180119. These data will be made publically available on December 31, 2021, and can be made available from the corresponding author prior to this date upon request.
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180119
List of Abbreviations
- WHO
- World Health Organization
- DRC
- The Democratic Republic of the Congo
- DMP
- Differentially methylated probe
- SWAN
- Subset-quantile within array normalization
- GO
- Gene ontology
